Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Yajneon Nov 17, 2022 1:56pm
183 Views
Post# 35107768

RE:RE:RE:RE:0.24 Seriously?

RE:RE:RE:RE:0.24 Seriously?Further to your post consultant99, I too have always liked the 'forced conversion' clause for warrants issued as part of a pp. In my experience the forced conversion number is usually set above the strike price but at least it's in place. Makes me wonder why more companies don't use this approach.

consultant99 wrote: Makes one wonder what the hurry was for the second PP if management knew this rule change was coming which would reduce the costs of financing and open up the financing to more shareholders.

Further expected news coming, assuming it was positive, could have started the financing from a higher price for the new offering.

I have seen other financing deals where the warrants have a proviso that a minimum number of days trading above the strike price automatically triggers exercising the warrants within 30 days. If the company needs the money this makes a lot of sense ...


<< Previous
Bullboard Posts
Next >>